Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?
2006 ◽
Vol 16
(1)
◽
pp. 277-282
◽
Keyword(s):
Phase Ii
◽
2009 ◽
Vol 35
(2)
◽
pp. 144-150
◽
2010 ◽
Vol 20
(3)
◽
pp. 428-433
◽